# US 2012/0238603 A1 · Treatment for inflammatory bowel disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0238603 A1
- Document ID: US20120238603A1
- Status: Published application
- Kind: A1
- Application number: 13/488,536
- Filed: 2012-06-05
- Published: 2012-09-20
- Earliest claimed: 2009-12-23
- Assignees: Sanofi
- Inventors: Anne MINNICH; Eszter BEKASI; Yong Mi CHOI-SLEDESKI
- Web page: https://patentgrep.com/patent/US20120238603A1

## CPC

- A61K 31/404: Indoles, e.g. pindolol
- A61K 9/2054: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a method for the treatment of an inflammatory bowel disease by the administration of the compound [4-(5-aminomethyl-2-fluorophenyl)piperidine-1-yl][7-fluoro-1-(2-methoxyethyl)-4-trifluoromethoxy-1H-indol-3-yl]methanone, which may be represented as Formula I: or a corresponding N-oxide, prodrug, pharmaceutically acceptable salt or solvate thereof.

## Claims

### Claim 1

A method of treating inflammatory bowel disease, comprising: administering to a patient in need thereof an effective amount of a compound of Formula I:
or a corresponding N-oxide, prodrug or pharmaceutically acceptable salt or solvate thereof.

### Claim 2 (depends on 1)

The method of claim 1 wherein the inflammatory bowel disease is Crohn's disease or ulcerative colitis

### Claim 3

A pharmaceutical composition for treating inflammatory bowel disease, comprising a compound of formula I, or a corresponding N-oxide, prodrug or pharmaceutically acceptable salt or solvate thereof, in combination with a pharmaceutically acceptable excipient.

### Claim 4

A method for the treatment of a human or non-human animal patient suffering from, or subject to, a condition that can be ameliorated by the administration of a pharmaceutically effective amount of a compound of Formula I, or a corresponding N-oxide, prodrug or a pharmaceutically acceptable salt or solvate thereof:
wherein the condition is selected from Crohn's disease and ulcerative colitis.
